Last updated: July 10, 2025
Sponsor: University of Texas at Austin
Overall Status: Active - Recruiting
Phase
N/A
Condition
Autism Spectrum Disorder (Asd)
Mild Cognitive Impairment
Attention Deficit/hyperactivity Disorder (Adhd - Adults)
Treatment
Transcranial photobiomodulation
Sham transcranial photobiomodulation
Clinical Study ID
NCT05802680
2019080005
Ages > 18 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- 18 years of age or older
Exclusion
Exclusion Criteria:
- None
Study Design
Total Participants: 500
Treatment Group(s): 2
Primary Treatment: Transcranial photobiomodulation
Phase:
Study Start date:
February 09, 2022
Estimated Completion Date:
February 01, 2027
Connect with a study center
The University of Texas at Austin
Austin, Texas 78712
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.